Artificial Intelligence: A Breakthrough in Eye Disease Prevention

Summary

T-Gency’s cutting-edge ERG-based prediction technology, powered by Artificial Intelligence (AI), is helping to prevent eye diseases before they progress. By enabling early detection through advanced analysis of ERG signals and demographic data, our solution is making a significant impact in the field of ocular health, reducing the risks of preventable blindness.

The Challenge

Eye diseases are a global concern, with millions at risk of preventable vision loss. The World Health Organization (WHO) estimates that more than 80% of eye diseases are preventable, yet early detection and intervention remain challenging. There was a need for an advanced, AI-driven solution that could analyze ocular health data and predict the onset of diseases in time to prevent severe outcomes.

Our Solution

To address this need, T-Gency developed an AI model that uses Electroretinogram (ERG) signals combined with demographic data to predict the likelihood of eye diseases such as Congenital Stationary Night Blindness (CSNB) and Retinitis Pigmentosa (RP). By analyzing these data points, our technology enables early diagnosis, allowing healthcare providers to take preventive measures that could save patients from vision loss.

Key Features:

• ERG Signal Analysis: Our system analyzes the electrical activity in the retina in response to visual stimuli, providing critical insights into ocular health.

• AI-Powered Prediction: Our model uses machine learning algorithms to predict the onset of specific eye diseases, helping ophthalmologists take early action.

• Keras-Based Prediction Model: The model, developed using Keras, can forecast whether a patient will develop conditions like CSNB or RP Type 1 to 3 or remain free of these diseases throughout life.

By implementing this solution, healthcare providers can offer better, more proactive care, significantly improving patient outcomes.

Technologies We Used

Our AI-driven solution leverages the following advanced technologies:

• ERG Signals (Electroretinogram): ERG signals record electrical activity in the retina, providing essential data on ocular health.

• Artificial Intelligence (AI): Machine learning algorithms analyze ERG data and demographic information to predict eye disease onset.

• Keras Prediction Model: The prediction model, built in Keras, forecasts the likelihood of developing specific eye diseases like CSNB and RP, offering valuable insights for early intervention.

Industries That Can Benefit from ERG-Based Prediction Technology

Our AI-driven prediction technology is not only transforming ocular health but also has broad applications across multiple sectors:

• Healthcare and Ocular Health: This solution helps ophthalmologists and healthcare providers diagnose eye diseases early and take preventive measures to protect vision.

• Medical Research: Researchers can use this data to understand the epidemiology of eye diseases further, driving advancements in treatment and prevention.

Why This Solution Matters?

T-Gency’s ERG-based prediction model offers significant advantages for various stakeholders:

• Improved Eye Disease Prevention: Our AI-powered solution enables early detection, allowing healthcare providers to prevent vision loss by addressing diseases before they progress.

• Enhanced Medical Research: The data generated by our model can aid in advancing research into the causes and treatments of eye diseases, driving innovations in ocular health.

• Personalized Patient Care: With real-time data and personalized predictions, patients receive tailored care plans based on their specific risk factors.

Who Needs These Solutions?

Our ERG-based prediction technology is essential for healthcare organizations, ophthalmologists, and medical researchers seeking to improve eye disease prevention and enhance patient care. By utilizing AI and ERG signals, we provide a powerful tool for reducing preventable blindness and advancing ocular health outcomes.